接受光子和质子放疗的头颈部肿瘤患者正电子发射断层扫描最大标准摄取值分析
本研究对100例匹配的口咽癌根治性放疗患者(IMPT 50例、IMRT 50例)比较治疗后3个月和6个月FDG PET的SUV,发现IMPT高摄取与低摄取区域的生物剂量有显著差异,但IMPT与IMRT在临床靶区原发灶的PET摄取在3个月和6个月随访时无显著差异,结论强调需进一步研究并与临床毒性结局关联。
要点
- IMPT高摄取与低摄取区域在3个月PET扫描上的生物剂量有显著差异。
- IMPT与IMRT在3个月和6个月临床靶区原发灶PET摄取无显著差异。
- 本研究未证实质子布拉格峰较高相对生物效应导致组织炎症的假设。
核心结论
- 研究未证实质子布拉格峰较高相对生物效应导致组织炎症的假设,结论强调需进一步研究并与临床毒性结局关联。
研究设计与样本
- 比较100例匹配的口咽癌根治性非手术放疗患者治疗后3个月和6个月FDG PET扫描,IMPT组50例、IMRT组50例。
主要发现
- IMPT组3个月治疗后扫描中高摄取与低摄取区域的生物剂量有显著差异。
- IMPT组与IMRT组在3个月和6个月随访时临床靶区原发灶PET摄取无显著差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 本文为短篇通讯,严格聚焦于SUV,未与毒性结局做相关性分析。
- 结论强调需进一步研究并与临床毒性结局最终关联。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: One main advantage of proton therapy versus photon therapy is its precise radiation delivery to targets without exit dose, resulting in lower dose to surrounding healthy tissues. This is critical, given the proximity of head and neck tumors to normal structures. However, proton planning requires careful consideration of factors, including air-tissue interface, anatomic uncertainties, surgical artifacts, weight fluctuations, rapid tumor response, and daily variations in setup and anatomy, as these heterogeneities can lead to inaccuracies in targeting and creating unwarranted hotspots to a greater extent than photon radiation. In addition, the elevated relative biological effectiveness at the Bragg peak's distal end can also increase hot spots within and outside the target area. METHODS AND MATERIALS: The purpose of this study was to evaluate for a difference in positron emission tomography (PET) standard uptake value (SUV) after definitive treatment, between intensity modulated proton therapy (IMPT) and intensity modulated photon therapy (IMRT). In addition, we compared the biologic dose between PET areas of high and low uptake within the clinical target volume-primary of patients treated with IMPT. This work is assuming that the greater SUV may potentially result in greater toxicities. For the purposes of this short communication, we are strictly focusing on the SUV and do not have correlation with toxicity outcomes. To accomplish this, we compared the 3- and 6-month posttreatment fluorodeoxyglucose PET scans for 100 matched patients with oropharyngeal cancer treated definitively without surgery using either IMPT (n = 50) or IMRT (n = 50). RESULTS: Our study found a significant difference in biologic dose between the high- and low-uptake regions on 3-month posttreatment scans of IMPT. However, this difference did not translate to a significant difference in PET uptake in the clinical target volume-primary at 3 and 6 months' follow-up between patients who received IMPT versus IMRT. CONCLUSIONS: Studies have proposed that proton's greater relative biological effectiveness at the Bragg peak could lead to tissue inflammation. Our study did not corroborate these findings. This study's conclusion underscores the need for further investigations with ultimate correlation with clinical toxicity outcomes.
引用
- Youssef I, Mohamed N, Kallini D, et al. An Analysis of Positron Emission Tomography Maximum Standard Uptake Value Among Patients With Head and Neck Cancer Receiving Photon and Proton Radiation. Int J Radiat Oncol Biol Phys. 2024. PMID: 38499254. doi:10.1016/j.ijrobp.2024.03.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。